Ibio Inc IBIO

Healthcare Biotechnology

iBio, Inc. is a preclinical stage biotechnology company that leverages artificial intelligence (AI) for the development of precision antibodies. The Company develops biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, prospectively enabling the discovery of new antibody treatments for hard-to-target cancers and other diseases. Its StableHu technology is an AI-based tool designed to predict a library of antibodies with fully human Complementarity-Determining Region (CDR) variants based on an input antibody. Its pre-clinical pipeline of immuno-oncology targets the treatment of solid tumors, glioblastoma, head, and neck cancers. Its pipeline includes IBIO-101, TROP-2 x CD3, MUC16, EGFRvIII, CCR8, and Target 5. IBIO-101 is an anti-CD25 monoclonal antibody (mAb) that has demonstrated in preclinical models of disease the ability to bind and deplete immunosuppressive regulatory T (Treg) cells to inhibit the growth of solid tumors.

NYSEAM:IBIO - Post by User

Ibio Inc

Bullboard Posts

Post by corOWNaviruson Mar 11, 2020 4:29pm

231 Views

Post# 30795407

CORONAVIRUS STOCKS ONLY PLAY IN TOWN

Simply put this is the greatest event since World War II All Coronavirus related stocks even the penny stocks remotely related to anything CORONAVIRUS WILL EXPLODE TO THE UPSIDE Greatest opportunity in a lifetime, unfortunately it is a virus that will kill many millions! This will not go away it will get enormous the cheapest stocks will give the biggest profits Good Luck to all

Bullboard Posts

@ the Bell: TSX advances to start off Christmas trading week